Tenet to Report its First Quarter 2026 Results on April 30th
Get Alerts THC Hot Sheet
Join SI Premium – FREE
DALLAS--(BUSINESS WIRE)-- Tenet Healthcare Corporation (NYSE: THC) will release its first quarter 2026 results before the market opens on Thursday, April 30, 2026, to be followed by a conference call at 9:00 a.m. Central Time (10:00 a.m. Eastern Time).
A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors.
About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We also operate a national portfolio of acute care and specialty hospitals, other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve. For more information, please visit www.tenethealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260331280019/en/
Investor Contact
Will McDowell
469-893-2387
[email protected]
Media Contact
Olivia E. Nadler
469-893-6352
[email protected]
Source: Tenet Healthcare Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS
- Greenix Pest Control Continues Commitment to Fight Lyme Disease, Donating $15,000 Over the Past Three Years
- Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share